Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer
US11447505B1 · kind B1 · utility
1Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2018 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Aug 27, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/0812
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application relates to a compound of Formula I, or a salt, hydrate or solvate thereof, as defined herein. The present compounds are found to have pharmacological effects, particularly at MRCK. Further provided are pharmaceutical compositions comprising said compounds. The present invention also relates to the use of these compounds as therapeutic agents, in particular, for the treatment and/or prevention of proliferative diseases, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.